RSL3 injection into keloid tissue dramatically decreased the mRNA levels of fibrotic genes, such as α-SMA, COL1A1, COL1A2, COL3A1, and FN1, and downregulated the ECM contents, according to qPCR analysis and the Sircol test (Figure 7F). The gene discussed is ACTA1; the disease is keloid.